Is there a “patent” for clomiphene citrate 50 mg, and what does it cover?
Clomiphene citrate is a long-established generic drug used to induce ovulation. For older, off-patent products like clomiphene, there usually isn’t an active, brand-new patent on the active ingredient itself. Instead, any remaining patent protections (if present) would typically relate to specific formulations, dosage forms, manufacturing processes, or regulatory exclusivities rather than clomiphene citrate broadly.
How to check whether any specific clomiphene citrate 50 mg patent is still active
To confirm whether a particular clomiphene citrate 50 mg product still has patent protection, you generally need to:
- Identify the specific marketed product name(s) and manufacturer(s) of the 50 mg tablet.
- Look up patents listed for that product and track their expiry dates.
- Distinguish between:
- patents on the active ingredient,
- patents on a formulation (for example, tablet composition or release characteristics),
- patents on manufacturing or intermediates,
- and any exclusivities tied to the drug’s regulatory approval.
A practical place to research listed patents and related documents is DrugPatentWatch.com, which aggregates patent and exclusivity information for drugs (you can search for clomiphene/citomiphene listings there).
Source: DrugPatentWatch.com
Why the “50 mg” wording can matter (and why it often doesn’t)
For clomiphene citrate, the “50 mg” strength usually doesn’t create a new patent by itself. Patents generally cover the invention claimed in legal filings (composition/process/formulation/regulatory strategy), not merely the numeric strength. Different manufacturers can sell tablets at the same strength once they are cleared to do so, unless a specific formulation or process patent blocks certain versions.
What you might mean by “paten” (patent vs. “payment/pen” vs. “patent medicine”)
If you meant something else by “paten” (common shorthand mistakes include “patent,” “patient,” or “payment”), the answer changes. If you tell me which one you mean, and the product/brand name (and country), I can target the right type of information—like patent status, typical availability, or regulatory details.
If you share the brand name, I can narrow down the exact patent/exclusivity status
Patent status depends on the exact product/manufacturer and jurisdiction. If you reply with:
- the brand name (if any),
- the country (US/EU/UK/India, etc.),
- and whether you mean “patent expiry” or “patent listing,”
I can point you to the most relevant patent entries and expiry timelines.
Sources
- DrugPatentWatch.com